Medtronic Inc. has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study,…
Category: Products & Tech
I may have been very late to the astonishing price increase of Glumetza, but I am, by coincidence, among the first to report that the generic price is almost as ridiculous. My bill, $14,009.23, was for the generic, available, as promised, in February 2016 and manufactured by Lupin, an Indian pharmaceutical company that is the sixth largest maker of generics in the world.
Type Zero Technologies' chief mathematician, Dr. Boris Kovatchev, reached out to Riding on Insulin to gauge interest in being part of a groundbreaking artificial pancreas trial.
LifeScan has introduced the new OneTouch Verio Flex blood glucose monitoring system, with ColorSure technology – a simple, accurate and easy-to-use…
Abbott Diabetes Care announced that it has obtained CE Mark for the FreeStyle Libre flash glucose monitoring system indicated for children and teens with diabetes aged 4-17 years old.
Bigfoot’s goal is to make pump-sensor therapy simpler than the pump companies before them have. They envision themselves as a service provider rather than a hardware or device company. Their service will be to “do a better job delivering insulin,” automating your between-meal insulin therapy, the communication between your pump and your Dexcom CGM, even so far as serving as a single point of contact for all of your supply and prescription inventory management, sending you supplies when you need them, “connecting everything, making it intuitive,” says Brewer.
Rather than telling patients they’re wrong, I try to give them the tools to make good decisions about their health. Guilt is not a motivator. And we tend to overlook baby steps. It’s not realistic to tell a patient to change their entire diet overnight. But asking a patient to cut out one thing, sodas, for example, can make a big impact on overall health.
The U.S. FDA has approved Animas Vibe Insulin Pump and Continuous Glucose Monitoring (CGM) System for management of diabetes in children and adolescents,…
Another insulin coming to us in 2016 is Lilly’s new basal insulin, Basaglar – a form of insulin glargine (which you may recognize if you’re familiar with Lantus). FDA approved it just this week after a patent dispute was finally resolved with Sanofi.
The U.S. FDA approved Basaglar (insulin glargine injection), the newest diabetes treatment from the Lilly-Boehringer Ingelheim diabetes…